Delivery Order SPE2DB22D2211-SPE2DB25FSFFL
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Dexmethylphenidate ER 20 mg capsules (100 count) with a ceiling value of $1,148.65. This non-competitive, firm fixed-price delivery order is set to conclude on September 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement under the company's existing...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Dexmethylphenidate ER 20 mg capsules (100 count) with a contract value of $1,636.86. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 8, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Dexmethylphenidate ER 20 mg capsules (100 count) with a ceiling value of $1,550.88. This is a firm fixed-price delivery order with an ultimate completion date of August 22, 2025, and represents a non-competitive set-aside award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Dexmethylphenidate ER 20 mg capsules (100-count units) with a ceiling value of $1,036.54. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Dexmethylphenidate ER 20 mg capsules (100-count units) valued at $5,320.50. This firm fixed-price delivery order represents a non-competitive set-aside and is scheduled for completion by September 16, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Dexmethylphenidate ER 15 mg capsules (100-count units) with a ceiling value of $1,276.17. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for ultimate completion by August 6, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,748.02 on September 15, 2025, for the supply of Dexmethylphenidate ER 20 mg capsules (100 count). This is a firm fixed price, non-set-aside delivery order with a completion date of September 16, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's ongoing pharmaceutical supply relationship with the...
- The Defense Logistics Agency awarded a delivery order valued at $1,656.97 to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Dexmethylphenidate ER 20 mg capsules (100 count). This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract. The order is scheduled for ultimate completion by August 18, 2025, with performance occurring at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order is issued...
- The Defense Logistics Agency awarded a $5,864.53 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Dexmethylphenidate ER 10 mg capsules (100 count). This is a firm fixed price, non-set-aside contract with a completion date of September 11, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a competitive award under AmerisourceBergen's existing contract vehicle with DLA. This award is issued...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,005.97 delivery order on August 27, 2025, for the supply of Dexmethylphenidate ER 10 mg capsules (100 count). This competitively awarded, firm fixed-price contract requires performance at AmerisourceBergen's corporate facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 28, 2025. No set-aside provisions were applied to this award. This delivery order is issued under AmerisourceBergen's existing...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSFFLDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Dexmethylphenidate ER 20 mg capsules in a quantity of 100 units, valued at $3,623.12. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract requires completion by September 19, 2025, and the pharmaceutical supply will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999 and extending through December 2026. As a critical pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen supplies a wide range of medications and medical commodities to support military and federal healthcare systems. The company's federal procurement portfolio demonstrates extensive capability in fulfilling varied pharmaceutical needs, from generic medications to specialty products, serving customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare organizations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 9/18/25 |